Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection

Journal of Experimental Medicine

Volumn 200, Issue 10, 2004, Pages 1337-1346

  Ma, Ge ^a   Greenwell Wild, Teresa ^a   Lei, Kejian ^a   Jin, Wenwen ^a   Swisher, Jennifer ^a   Hardegen, Neil ^a   Wild, Carl T ^b   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b Panacos Pharmaceuticals   (United States)

Author keywords

AIDS; Fusion; Monocytes; Phosphatidylserine; Retrovirus

Indexed keywords

COMPLEMENTARY DNA; LIPOCORTIN 2; PHOSPHATIDYLSERINE; RNA; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SMALL INTERFERING RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MASS SPECTROMETRY; MEMBRANE BINDING; MONOCYTE; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ANNEXIN A2; BLOTTING, WESTERN; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPRECIPITATION; MACROPHAGES; MASS SPECTROMETRY; MICROSCOPY, FLUORESCENCE; PHOSPHATIDYLSERINES; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR;

EID: 9244260537     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041115     Document Type: Article

References (46)

1. Thompson, R.C., and K. Ohlsson. 1986. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA. 83:6692-6696.
2. McNeely, T.B., M. Dealy, D.J. Dripps, J.M. Orenstein, S.P. Eisenberg, and S.M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96:456-464.
3. McNeely, T.B., D.C. Shugars, M. Rosendahl, C. Tucker, S.P. Eisenberg, and S.M. Wahl. 1997. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood. 90:1141-1149.
4. Zhang, Y., D.L. DeWitt, T.B. McNeely, S.M. Wahl, and L.M. Wahl. 1997. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J. Clin. Invest. 99:894-900.
5. Hiemstra, P.S., S. van Wetering, and J. Stolk. 1998. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium. Eur. Respir. J. 12:1200-1208.
6. Song, X., L. Zeng, W. Jin, J. Thompson, D.E. Mizel, K. Lei, R.C. Billinghurst, A.R. Poole, and S.M. Wahl. 1999. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J. Exp. Med. 190:535-542.
7. Jin, F.Y., C. Nathan, D. Radzioch, and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell. 88:417-426.
8. Ashcroft, G.S., K. Lei, W. Jin, G. Longenecker, A.B. Kulkarni, T. Greenwell-Wild, H. Hale-Donze, G. McGrady, X.Y. Song, and S.M. Wahl. 2000. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 6:1147-1153.
9. Zhu, J., C. Nathan, W. Jin, D. Sim, G.S. Ashcroft, S.M. Wahl, L. Lacomis, H. Erdjument-Bromage, P. Tempst, C.D. Wright, and A. Ding. 2002. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell. 111:867-878.
10. Berger, E.A., P.M. Murphy, and J.M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
11. Stevenson, M. 2003. HIV-1 pathogenesis. Nat. Med. 9:853-860.
12. Orenstein, J.M., C. Fox, and S.M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science. 276:1857-1861.
13. Freed, E.O., and M.A. Martin. 2001. HIVs and their replication. In Fields Virology. D.M. Knipe and P.M. Howley, editors. Lippincott Williams and Wilkins, Philadelphia, PA. 1971-2041.
14. Callahan, M.K., P.M. Popernack, S. Tsutsui, L. Truong, R.A. Schlegel, and A.J. Henderson. 2003. Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J. Immunol. 170:4840-4845.
15. Gerke, V., and S.E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82:331-371.
16. Brownstein, C., A.B. Deora, A.T. Jacovina, R. Weintraub, M. Gertler, K.M. Khan, D.J. Falcone, and K.A. Hajjar. 2004. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood. 103:317-324.
17. Waisman, D.M. 1995. Annexin II tetramer: structure and function. Mol. Cell. Biochem. 149:301-322.
18. Mollenhauer, J. 1997. Annexins: what are they good for? Cell. Mol. Life Sci. 53:506-507.
19. Raynor, C.M., J.F. Wright, D.M. Waisman, and E.L. Pryzdial. 1999. Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry. 38:5089-5095.
20. Malhotra, R., M. Ward, H. Bright, R. Priest, M.R. Foster, M. Hurle, E. Blair, and M. Bird. 2003. Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect. 5:123-133.
21. Hale-Donze, H., T. Greenwell-Wild, D. Mizel, T.M. Doherty, D. Chatterjee, J.M. Orenstein, and S.M. Wahl. 2002. Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteria. J. Immunol. 169:3854-3862.
22. Wahl, S.M., T. Greenwell-Wild, G. Peng, H. Hale-Donze, T.M. Doherty, D. Mizel, and J.M. Orenstein. 1998. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc. Natl. Acad. Sci. USA. 95:12574-12579.
23. Nussbaum, O., C.C. Broder, and E.A. Berger. 1994. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:5411-5422.
24. Fan, X., S. Krahling, D. Smith, P. Williamson, and R.A. Schlegel. 2004. Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol. Biol. Cell. 15:2863-2872.
25. Callahan, M.K., M.S. Halleck, S. Krahling, A.J. Henderson, P. Williamson, and R.A. Schlegel. 2003. Phosphatidylserine expression and phagocytosis of apoptotic thymocytes during differentiation of monocytic cells. J. Leukoc. Biol. 74:846-856.
26. Patel, R.A., and F.T. Crews. 1992. Membrane lipids and dynamics in the enveloped virus life cycle. In Membrane Interactions of HIV-1. R.C. Aloia and C.C. Curtain, editors. Wiley-Liss Inc., New York. 237-253.
27. Zobiack, N., U. Rescher, S. Laarmann, S. Michgehl, M.A. Schmidt, and V. Gerke. 2002. Cell-surface attachment of pedestal-forming enteropathogenic E. coli induces a clustering of raft components and a recruitment of annexin 2. J. Cell Sci. 115:91-98.
28. Mayran, N., R.G. Parton, and J. Gruenberg. 2003. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J. 22:3242-3253.
29. Filipenko, N.K., and D.M. Waisman. 2001. The C terminus of annexin II mediates binding to F-actin. J. Biol. Chem. 276:5310-5315.
30. Chan, D.C., and P.S. Kim. 1998. HIV entry and its inhibition. Cell. 93:681-684.
31. Saphire, A.C., M.D. Bobardt, Z. Zhang, G. David, and P.A. Gallay. 2001. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol. 75:9187-9200.
32. Bristow, C.L., D.R. Mercatante, and R. Kole. 2003. HIV-1 preferentially binds receptors copatched with cell-surface elastase. Blood. 102:4479-4486.
33. Greene, W.C., and B.M. Peterlin. 2002. Charting HIV's remarkable voyage through the cell: basic science as a passport to future therapy. Nat. Med. 8:673-680.
34. Vazquez, N., T. Greenwell-Wild, and S.M. Wahl. 2001. HIV-1 infection and signaling pathways in human macrophages. FASEB J. 15:A1011.
35. Schubert, U., D.E. Ott, E.N. Chertova, R. Welker, U. Tessmer, M.F. Princiotta, J.R. Bennink, H.G. Krausslich, and J.W. Yewdell. 2000. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. USA. 97:13057-13062.
36. Osborn, L., S. Kunkel, and G.J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA. 86:2336-2340.
37. Chen, B.K., M.B. Feinberg, and D. Baltimore. 1997. The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol. 71:5495-5504.
38. Ferraro-Peyret, C., L. Quemeneur, M. Flacher, J.P. Revillard, and L. Genestier. 2002. Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytes. J. Immunol. 169:4805-4810.
39. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184:39-51.
40. Pomerantz, R.J. 2003. HIV: cross-talk and viral reservoirs. Nature. 424:136-137.
41. Wahl, S.M., J.M. Orenstein, and P.D. Smith. 1996. Macrophage function in HIV infection. In Immunology of HIV Infection. S. Gupta, editor. Plenum Press, New York. 303-336.
42. Kornbluth, R.S. 1994. Significance of T cell apoptosis for macrophages in HIV infection. J. Leukoc. Biol. 56:247-256.
43. Pelchen-Matthews, A., B. Kramer, and M. Marsh. 2003. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162:443-455.
44. Beaton, A.R., J. Rodriguez, Y.K. Reddy, and P. Roy. 2002. The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release. Proc. Natl. Acad. Sci. USA. 99:13154-13159.
45. Gould, S.J., A.M. Booth, and J.E. Hildreth. 2003. The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. USA. 100:10592-10597.
46. Wahl, S.M., N. Vazquez, T. Greenwell-Wild, G. Ma, G. Peng, and J.M. Orenstein. 2003. Viral and host co-factors facilitate HIV replication in macrophages. J. Leukoc. Biol. 74:726-735.